Office for Life Sciences Bulletin – 26 March 2021
OLS Introduction The Office for Life Sciences (OLS) is a joint unit between the Department of Health & Social Care (DHSC) and Department for Business, Energy & Industrial Strategy (BEIS). This bulletin aims to keep the life sciences sector up to date on the latest guidance and during the Coronavirus (COVID-19) outbreak, providing you with information from Government to help your members and networks prepare. If you would like to be added to the distribution list, please email nita.bhanot@beis.gov.uk For any questions on the UK/EU Trade and Cooperation Agreement, please contact euexit@officeforlifesciences.gov.uk
News NEW – The Government has published an ambitious vision for the future of clinical research delivery. Saving and improving lives: the future of UK clinical research delivery sets out to create more efficient research delivery, more diverse and accessible research, and to embed research in the NHS. Launch of the UK-wide vision will be followed by implementation plans and strategies setting out how the UK government and devolved administrations will work to deliver the vision during 2021 to 2022. For more information, click here. NEW – The MHRA are running a pilot asking for evidence of patient involvement in drug development for clinical trials and marketing authorisation (new active substance or new indication) applications. The pilot will run until they have sufficient information from a variety of application types. For more information, click here. UPDATED – Guidance has been updated to include a summary of changes to the lockdown rules in England from 29 March. For more information, click here.
Regulation
NEW – Guidance has been published for the veterinary pharmaceutical industry on how to apply for and maintain a joint-label for use on veterinary medicines placed on the market in the UK and Ireland. For more information, click here.